Latest news

Insights

Can AI Predict Regulatory Outcomes in Pharma and Biotech?

Executive Summary AI can partially predict regulatory outcomes in pharma and biotech, but it cannot replace regulatory judgment. In 2026,...
Insights

Market Access Challenges in Pharmaceuticals: Pricing, Policy, and Payer Pressure

Executive Summary Market access challenges in pharmaceuticals in 2026 are defined by increasing pricing pressure, evolving policy frameworks, and more...
Insights

Why Is Market Access Becoming More Difficult for Pharma Companies?

Executive Summary Market access is becoming more difficult for pharma companies in 2026 due to a convergence of pricing pressure,...
Insights

Launch Readiness in Pharma: Overcoming Market Entry Barriers

Executive Summary Launch readiness in pharma in 2026 is defined by the ability to overcome market entry barriers across pricing,...
Insights

The Role of AI and Data in Driving Pharma Innovation

Executive Summary AI and data are now central to driving...
Insights

Innovation vs Regulation in Life Sciences: Can Companies Balance Both?

Innovation vs Regulation:Executive Summary Yes—life sciences companies can balance innovation...
Insights

Responding to Patent Expirations and Generic Competition

Executive Summary Patent expiration refers to the end of market exclusivity, after which generic or biosimilar competitors can enter. Pharma...
Clinical

Travere’s Filspari becomes the first FDA-approved medication for FSGS

Travere Therapeutics had a long and rocky road to take its drug Filspari to patients with focal segmental glomerulosclerosis...
Insights

How Pharma Companies Are Adapting to Market Disruption

Executive Summary Pharma companies are adapting to market disruption in 2026 by shifting from traditional, linear operating models to integrated,...
Insights

How Is AI Transforming Market Access and Commercial Decision-Making?

AI Transforming:Executive Summary AI is transforming market access and commercial...
Insights

How Are Biotech Firms Building Resilient Innovation Pipelines?

Executive Summary Biotech firms are building resilient innovation pipelines in...
Clinical

IDEAYA and Servier Report Phase 2/3 Trial Success for Darovasertib Combination in Uveal Melanoma

IDEAYA Biosciences and Servier announced that their investigational combination therapy met the primary endpoint in a mid-to-late-stage clinical trial...
Commercial

Regeneron Partners with Telix in Radiopharmaceutical Collaboration Covering Up to Eight Cancer Programs

Regeneron Pharmaceuticals has entered the radiopharmaceutical sector through a collaboration with Telix Pharmaceuticals, aiming to develop treatments across multiple...
Clinical

Revolution Meets Key Survival Goals With RAS Inhibitor In Important Trial

Revolution Medicines reported that its pan-RAS inhibitor enabled patients with an aggressive form of pancreatic cancer to survive roughly...
Commercial

Regeneron Partners with Telix in Radiopharmaceutical Collaboration Covering Up to Eight Cancer Programs

Regeneron Pharmaceuticals has entered the radiopharmaceutical sector through a...
Editorial Team -
Commercial

AbbVie Acquires Gilgamesh’s Lead Psychedelic Drug Candidate for Up to $1.2 Billion

A Major Move in Neuroscience AbbVie has reached an agreement...
Commercial

Former Inizio Evoke Executives Launch Flex Marketing

A group of former executives from health communications firm...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team -

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers...
Editorial Team -

Regulatory

Insights

Market Access Challenges in Pharmaceuticals: Pricing, Policy, and Payer Pressure

Executive Summary Market access challenges in pharmaceuticals in 2026 are...
Insights

Why Is Market Access Becoming More Difficult for Pharma Companies?

Executive Summary Market access is becoming more difficult for pharma...
Insights

Launch Readiness in Pharma: Overcoming Market Entry Barriers

Executive Summary Launch readiness in pharma in 2026 is defined...
Insights

What Commercial Strategy Mistakes Do Biotech Companies Make?

Executive Summary Biotech companies in 2026 most commonly fail commercially...

Research & Development

Market Access

Manufacturing

Lilly’s Plan to Build $3B Dutch Plant Underway, 500 Hires Also in the Pipeline

Eli Lilly Expands European Manufacturing with a $3 Billion...
Manufacturing

Alkermes plans to acquire Avadel and its long-acting narcolepsy medication Lumryz for $2.1 billion

Alkermes, which plans to spend up to $2.1 billion...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

Can AI Predict Regulatory Outcomes in Pharma and Biotech?

Executive Summary AI can partially predict regulatory outcomes in pharma...
Editorial Team -
Manufacturing

UCB to Build $2 Billion Biologics Manufacturing Facility in Georgia

Belgium-based UCB has announced plans to invest $2 billion...
Editorial Team -
Insights

Why Is Market Access Becoming More Difficult for Pharma Companies?

Executive Summary Market access is becoming more difficult for pharma...
Editorial Team -